Aspirin Monotherapy beyond 12 Months of Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction: Oldies But Goodies?

摘要

Current guidelines recommend that continuing dual antiplatelet therapy (DAPT) beyond 12 months may be reasonable in some patients with acute coronary syndrome (ACS). These include patients with non-ST elevation (NSTE)-ACS or ST-elevation myocardial infarction (STEMI) treated with coronary stent implantation who have tolerated DAPT without a bleeding complication and do not present a high bleeding risk.